Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125634723 | 12563472 | 3 | F | 20000322 | 20160720 | 20160715 | 20160727 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0617 | BRISTOL MYERS SQUIBB | 42.00 | YR | M | Y | 0.00000 | 20160727 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125634723 | 12563472 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 200 MG, TID | 130200 | MG | N | 20972 | 200 | MG | CAPSULE | TID | |||
125634723 | 12563472 | 2 | SS | VIDEX | DIDANOSINE | 1 | Oral | RESTARTED ON 29-DEC-2000 AT 300 MG DAILY | 10000 | MG | N | 0 | 300 | MG | TABLET | QD | |||
125634723 | 12563472 | 3 | SS | VIDEX | DIDANOSINE | 1 | Oral | 100 MG, BID | 10000 | MG | N | 0 | 100 | MG | TABLET | BID | |||
125634723 | 12563472 | 4 | SS | VIDEX | DIDANOSINE | 1 | Oral | 200 MG, BID | 10000 | MG | N | 0 | 200 | MG | TABLET | BID | |||
125634723 | 12563472 | 5 | SS | VIDEX | DIDANOSINE | 1 | Oral | 100 MG, BID | 10000 | MG | N | 0 | 100 | MG | TABLET | BID | |||
125634723 | 12563472 | 6 | SS | VIDEX | DIDANOSINE | 1 | Oral | 250 MG, UNK | 10000 | MG | N | 0 | 250 | MG | TABLET | ||||
125634723 | 12563472 | 7 | SS | ZERIT | STAVUDINE | 1 | Oral | FORM CAPS; INITIAL 30MG BID FROM 24SEP97 TO 18AUG99; RESTART ON 29-DEC-2006 @ 80 MG DAILY; | 41640 | MG | N | 0 | 30 | MG | CAPSULE | BID | |||
125634723 | 12563472 | 8 | SS | ZERIT | STAVUDINE | 1 | Oral | FORM CAPS; INITIAL 30MG BID FROM 24SEP97 TO 18AUG99; RESTART ON 29-DEC-2006 @ 80 MG DAILY; | 41640 | MG | N | 0 | 80 | MG | CAPSULE | QD | |||
125634723 | 12563472 | 9 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 8 CAP AES#DOSE_FREQUENCY: DLY | N | 0 | 8 | DF | QD | ||||||
125634723 | 12563472 | 10 | SS | INTELENCE | ETRAVIRINE | 1 | Oral | TABS | 0 | 200 | MG | TABLET | BID | ||||||
125634723 | 12563472 | 11 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | TABLETS | 0 | 1200 | MG | TABLET | QD | ||||||
125634723 | 12563472 | 12 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | TABS 1DF:1DOSE | 0 | 1 | DF | TABLET | QD | ||||||
125634723 | 12563472 | 13 | SS | NORVIR | RITONAVIR | 1 | Oral | 300 MG, BID | 130200 | MG | N | 0 | 300 | MG | CAPSULE | BID | |||
125634723 | 12563472 | 14 | SS | NORVIR | RITONAVIR | 1 | Oral | 600 MG, BID | 130200 | MG | N | 0 | 600 | MG | CAPSULE | BID | |||
125634723 | 12563472 | 15 | SS | NORVIR | RITONAVIR | 1 | Oral | 600 MG, QD | 130200 | MG | N | 0 | 600 | MG | CAPSULE | QD | |||
125634723 | 12563472 | 16 | SS | NORVIR | RITONAVIR | 1 | Oral | 200 MG, QD | 130200 | MG | N | 0 | 200 | MG | CAPSULE | QD | |||
125634723 | 12563472 | 17 | SS | NORVIR | RITONAVIR | 1 | Oral | 200 MG, QD | 0 | 200 | MG | TABLET | QD | ||||||
125634723 | 12563472 | 18 | SS | PROZEI | AMPRENAVIR | 1 | Oral | 1500 MG, QD | N | 0 | 1500 | MG | CAPSULE | QD | |||||
125634723 | 12563472 | 19 | SS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 800 MG, QD | 0 | 800 | MG | TABLET | QD | ||||||
125634723 | 12563472 | 20 | C | ZIAGEN | ABACAVIR SULFATE | 1 | Oral | 600 MG AES#DOSE_FREQUENCY: DLY | U | 0 | 300 | MG | TABLET | BID | |||||
125634723 | 12563472 | 21 | C | INVIRASE | SAQUINAVIR MESYLATE | 1 | Oral | 400 MG, BID | U | 0 | 400 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125634723 | 12563472 | 1 | HIV infection |
125634723 | 12563472 | 2 | HIV infection |
125634723 | 12563472 | 7 | HIV infection |
125634723 | 12563472 | 9 | HIV infection |
125634723 | 12563472 | 10 | HIV infection |
125634723 | 12563472 | 11 | HIV infection |
125634723 | 12563472 | 12 | HIV infection |
125634723 | 12563472 | 13 | HIV infection |
125634723 | 12563472 | 17 | HIV infection |
125634723 | 12563472 | 18 | HIV infection |
125634723 | 12563472 | 19 | HIV infection |
125634723 | 12563472 | 20 | HIV infection |
125634723 | 12563472 | 21 | HIV infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125634723 | 12563472 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125634723 | 12563472 | Hepatic cirrhosis | |
125634723 | 12563472 | Hypertriglyceridaemia | |
125634723 | 12563472 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125634723 | 12563472 | 1 | 19990819 | 20040331 | 0 | |
125634723 | 12563472 | 2 | 20001229 | 20060410 | 0 | |
125634723 | 12563472 | 3 | 19951018 | 19951206 | 0 | |
125634723 | 12563472 | 4 | 19951207 | 19960313 | 0 | |
125634723 | 12563472 | 5 | 19960314 | 19960723 | 0 | |
125634723 | 12563472 | 6 | 19960724 | 19970924 | 0 | |
125634723 | 12563472 | 7 | 19970924 | 19990818 | 0 | |
125634723 | 12563472 | 8 | 20001229 | 20060410 | 0 | |
125634723 | 12563472 | 9 | 20001229 | 20060410 | 0 | |
125634723 | 12563472 | 10 | 20081011 | 0 | ||
125634723 | 12563472 | 11 | 20061011 | 0 | ||
125634723 | 12563472 | 12 | 20060411 | 0 | ||
125634723 | 12563472 | 13 | 19990819 | 20000331 | 0 | |
125634723 | 12563472 | 14 | 19961218 | 19970924 | 0 | |
125634723 | 12563472 | 15 | 20000401 | 20001228 | 0 | |
125634723 | 12563472 | 16 | 20060411 | 20110608 | 0 | |
125634723 | 12563472 | 17 | 20110608 | 0 | ||
125634723 | 12563472 | 18 | 20040401 | 20051110 | 0 | |
125634723 | 12563472 | 19 | 20070807 | 0 | ||
125634723 | 12563472 | 20 | 19990819 | 20001228 | 0 | |
125634723 | 12563472 | 21 | 19990819 | 20001229 | 0 |